Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P04626 (
erbB-2
)
5,251
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The specific tyrosine phosphorylation of
glucose-6-phosphate dehydrogenase
(
G6PDH
) by the
epidermal growth factor (EGF) receptor
in vitro is demonstrated. The Km values of the substrate
G6PDH
and of ATP for the receptor tyrosine kinase were ca. 1 and 10 microM, respectively. The rate of phosphorylation was EGF dependent, with a four-fold increase in Vmax in the presence of EGF. The phosphorylation was stimulated maximally by 0.2 microM or greater EGF, with an ED50 of ca. 20 nM which is consistent with the affinity of the solubilized receptor for EGF. Using conditions of 5 microM
G6PDH
, 100 microM ATP, 5 mM Mg2+, and 1 mM Mn2+, up to 0.3 mol phosphate was incorporated into 1 mol of the 55-kDa subunit of Baker's yeast
G6PDH
. Tryptic peptide mapping revealed several unique phosphopeptides for both Baker's yeast and bovine adrenal
G6PDH
. The patterns of phosphopeptides for a given enzyme were identical for basal and EGF-stimulated phosphorylation.
...
PMID:Epidermal growth factor receptor tyrosine kinase phosphorylation of glucose-6-phosphate dehydrogenase in vitro. 312 60